NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Xie R, Cheng L, Huang M, Huang L, et al. Cancer Res 2023 Mar 20:CAN-22-2233. doi: 10.1158/0008-5472.CAN-22-2233.

Read + Share

Amedeo Smart

Independent Medical Education

Xie R, Cheng L, Huang M, Huang L, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res 2023 Mar 20:CAN-22-2233. doi: 10.1158/0008-5472.CAN-22-2233.
PMID: 36939377